简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
02812.HK
Samsung CSI China Dragon Internet ETF (02812.HK) Falls 1.05% to HKD 11.310
Tags:
Samsung CSI China Dragon Internet ETF
02812.HK
ETF
2026-08-13
Samsung CSI China Dragon Internet ETF (02812.HK) Falls 2.28%, Trades at 0.11% Discount
Tags:
Samsung CSI China Dragon Internet ETF
02812.HK
ETF
2026-08-06
Samsung CSI China Dragon Internet ETF (02812.HK) Rises 1.21%, Turnover Reaches HKD 594,000
Tags:
Samsung CSI China Dragon Internet ETF
02812.HK
ETF
2026-08-03
Samsung CSI China Dragon Internet ETF (02812.HK) Rises 3.76% to HK$12.430
Tags:
Samsung CSI China Dragon Internet ETF
02812.HK
ETF
2026-04-16
Commercial Recovery and Valuation Rebound Narrative Continues, Samsung CSI China Dragon Internet ETF (02812.HK) Surges 3.51%
Tags:
NewTimeSpace
02812.HK
2026-02-23
After sliding for several consecutive sessions, Samsung CSI China Dragon Internet ETF (02812.HK) dropped 2.84%.
Tags:
NewTimeSpace
Samsung CSI China Dragon Internet ETF
02812.HK
2026-01-08
Samsung CSI China Dragon Internet ETF (02812.HK) continued to decline in the afternoon, dropping more than 2%! A globally positioned listed leading Chinese internet enterprise
Tags:
Samsung CSI China Dragon Internet ETF,
02812.HK
Tencent
2026-01-07
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App